Description
Opinion Only. Not for Medical Reference.
Semax
For neurodegenerative issues (Dementia, Alzheimer’s, Parkinson’s). Has cognitive function and memory formation mechanisms. Also neuroprotection in stroke and injury models.
The FDA is meeting with the Pharmacy Compounding Advisory Committee (PCAC) on 7/24/26 to evaluate Semax forcerebral ischemia, migraine, and trigeminal neuralgia.
Dosage: 200–600 mcg/day, often cycled (10–14 days on, 2–3 off); effects build over 3–7 days
